November 24, 2010
For immediate release
OTTAWA – Health Canada is informing Canadians that McNeil Consumer Healthcare (Canada) is conducting a voluntary recall of Children’s Benadryl Allergy Meltaways tablets sold in Canada. McNeil is requesting that wholesalers and pharmacies immediately stop sale of this product.
The recall of the marketed lots is being conducted as a precautionary measure since the company has identified quality control concerns only on lots that had not been released for sale. It is important to note that no associated adverse reactions have been reported to Health Canada.
Health Canada reminds Canadians who have concerns about these products to consult with their health care practitioner or contact the company at 1-888-222-6036 or visit: www.mcneilcanada.com.
Health Canada will continue to monitor the safety of health products on the Canadian market, including those manufactured at McNeil Consumer Healthcare plants and will inform Canadians if new safety information arises. Canadians can be confident that should any risks to health be identified, Health Canada will take immediate and appropriate actionto help protect the health and safety of Canadians.